title: The periodontal-systemic connection: implications for treatment of patients with osteoporosis and periodontal disease.
abstract: Osteoporosis and osteopenia may influence periodontal disease and tooth loss. Medications such as hormone replacement therapy and nutritional supplements that are used to prevent or treat osteoporosis have been evaluated for beneficial effects on oral health in a small number of human studies. Hormone replacement therapy (HRT), which slows the rate of bone loss at skeletal sites such as the hip and spine, also appears to reduce the rate of alveolar bone loss in postmenopausal women. HRT use is consistently associated with greater tooth retention and a reduced likelihood of edentulism in studies of elderly women. The number of studies on the effects of calcium or vitamin D intake on oral outcomes is limited, but suggest that higher intake levels are associated with reduced prevalence of clinical attachment loss and lower risk of tooth loss. Data from a prospective study of oral health in men show a similar association between higher calcium intake and reduced alveolar bone loss. The number of teeth with progression of alveolar bone loss over a 7-year period was significantly lower among men whose calcium intake was at least 1,000 mg per day, compared to men with a calcium intake below this level. Future studies should confirm these findings and evaluate the oral effects of new medications for osteoporosis. If confirmed, the implications for dental professionals may include an expanded array of medications for the treatment of periodontal disease and a greater emphasis on nutrition education for patients.
authors.affiliation: Department of Health Policy and Health Services Research, Boston University Goldman School of Dental Medicine, Boston, Massachusetts, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Krall
mesh_terms: D000368:Aged; D016301:Alveolar Bone Loss / Q000503:physiopathology* / Q000517:prevention & control / Q000628:therapy; D000704:Analysis of Variance; D002136:Calcium, Dietary / Q000008:administration & dosage; D016009:Chi-Square Distribution; D019587:Dietary Supplements; D018450:Disease Progression; D005247:Feeding Behavior; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D052756:Nutritional Sciences / Q000193:education; D010024:Osteoporosis / Q000503:physiopathology* / Q000628:therapy; D010512:Periodontal Index; D011446:Prospective Studies; D012907:Smoking; D013223:Statistics as Topic; D014807:Vitamin D / Q000008:administration & dosage
chemical_list: D002136:Calcium, Dietary; D014807:Vitamin D